Analysis of VEGF receptors and microvessel density in NMU-induced breast cancer under the influence of platelet factor 4 and rapamycin

Breast cancer is the main killer disease among women worldwide and the second most common cause of cancer death in women in the United States. Angiogenesis is the formation of a new vascular network from the pre-existing vessels. It is a normal and vital process for growth and development as well...

Full description

Saved in:

Bibliographic Details
Main Author:	Muhammad Sakri, Muhammad Shahidan
Format:	Thesis
Language:	English
Published:	2015
Subjects:	RG Gynecology and obstetrics
Online Access:	http://eprints.usm.my/40538/1/Dr._Muhammad_Shahidan_Muhammad_Sakri_%29-24_pages.pdf
Tags:	Add Tag No Tags, Be the first to tag this record!

id	my-usm-ep.40538
record_format	uketd_dc
spelling	my-usm-ep.405382018-05-23T07:17:59Z Analysis of VEGF receptors and microvessel density in NMU-induced breast cancer under the influence of platelet factor 4 and rapamycin 2015 Muhammad Sakri, Muhammad Shahidan RG Gynecology and obstetrics Breast cancer is the main killer disease among women worldwide and the second most common cause of cancer death in women in the United States. Angiogenesis is the formation of a new vascular network from the pre-existing vessels. It is a normal and vital process for growth and development as well as in wound healing and in the formation of granulation tissue. Neovasculation or angiogenesis play a pivotal role in the supply of essential nutrients and oxygen for cell growth and also providing passageway for tumour metastasis. Currently, angiogenesis is being intensively studied to inhibit tumour progression by blocking the process. In this study, the rats model were induced N-nitroso-N-methylurea (NMU) to cause invasive mammary tumourigenesis. The rats were divided into 4 groups based on treatment given; rapamycin, PF4 and drug combination. The rapamycin and PF4 were administered as single agent or in combination to determine the anti-tumour and anti-angiogenic effects as well as to evaluate their nature when combined. Flt-1, Flk-1, and Flt-4 were selected as markers for downstream mediators which represent the process of tumour angiogenesis, differentiation, cell proliferation and vascular permeability of NMU-model while CD34 marker had been selected for microvessel density (MVD) counting. The protein expressions and gene expression of these markers were evaluated using immunohistochemistry analysis and Real-time PCR assay. Findings from the control group had demonstrated that the severity of malignancy significantly increased with the progression of the mammary tumour. Development of less-aggressive lesion that was histologically classified as Invasive Ductal Carcinoma (IDC)-Cribriform subtype was predominant in small sizes of tumour. In contrast, development of more-aggressive lesions that were histologically classified as IDC-Papillary and Not Otherwise Specified (NOS) subtypes were seen in larger sizes of tumour. In the treatment group, rapamycin treatment had been found to show significant inhibition of mammary tumour progression as well as tumour angiogenesis at protein and gene level. All VEGF signaling receptor markers expressions were significantly suppressed which were associated to significant tumour regression. Treatment with PF4 alone is not effective to inhibit the tumour angiogenesis. This was reflected in the insignificant inhibition of Flt-1, Flk-1 and Flt- 4 expression. The drug combination had obtained a significant down-regulation of Flt-1, Flk-1 and Flt-4 at protein and gene level but no synergistic effects were seen. Microvessel density counting had revealed that there is correlation (p<0.01) between the existing of capillary and the expression of VEGF signaling molecule receptors. Less capillary formation was observed in less aggressive tumours while the converse was seen in aggressive tumours. Thus, the present findings had suggested that rapamycin was not synergistic or additive to PF4. In fact, PF4 might be antagonist towards the action of rapamycin as anti-tumour and anti-angiogenesis. Present findings had concluded that rapamycin is a potent anti-angiogenic agent for the invasive NMU-induced mammary carcinoma in the rat model and has the potential to be applied clinically as an anti-angiogenic therapy for the treatment of advanced stages of breast cancer. 2015 Thesis http://eprints.usm.my/40538/ http://eprints.usm.my/40538/1/Dr._Muhammad_Shahidan_Muhammad_Sakri_%29-24_pages.pdf application/pdf en public masters Universiti Sains Malaysia Pusat Pengajian Sains Perubatan
institution	Universiti Sains Malaysia
collection	USM Institutional Repository
language	English
topic	RG Gynecology and obstetrics
spellingShingle	RG Gynecology and obstetrics Muhammad Sakri, Muhammad Shahidan Analysis of VEGF receptors and microvessel density in NMU-induced breast cancer under the influence of platelet factor 4 and rapamycin
description	Breast cancer is the main killer disease among women worldwide and the second most common cause of cancer death in women in the United States. Angiogenesis is the formation of a new vascular network from the pre-existing vessels. It is a normal and vital process for growth and development as well as in wound healing and in the formation of granulation tissue. Neovasculation or angiogenesis play a pivotal role in the supply of essential nutrients and oxygen for cell growth and also providing passageway for tumour metastasis. Currently, angiogenesis is being intensively studied to inhibit tumour progression by blocking the process. In this study, the rats model were induced N-nitroso-N-methylurea (NMU) to cause invasive mammary tumourigenesis. The rats were divided into 4 groups based on treatment given; rapamycin, PF4 and drug combination. The rapamycin and PF4 were administered as single agent or in combination to determine the anti-tumour and anti-angiogenic effects as well as to evaluate their nature when combined. Flt-1, Flk-1, and Flt-4 were selected as markers for downstream mediators which represent the process of tumour angiogenesis, differentiation, cell proliferation and vascular permeability of NMU-model while CD34 marker had been selected for microvessel density (MVD) counting. The protein expressions and gene expression of these markers were evaluated using immunohistochemistry analysis and Real-time PCR assay. Findings from the control group had demonstrated that the severity of malignancy significantly increased with the progression of the mammary tumour. Development of less-aggressive lesion that was histologically classified as Invasive Ductal Carcinoma (IDC)-Cribriform subtype was predominant in small sizes of tumour. In contrast, development of more-aggressive lesions that were histologically classified as IDC-Papillary and Not Otherwise Specified (NOS) subtypes were seen in larger sizes of tumour. In the treatment group, rapamycin treatment had been found to show significant inhibition of mammary tumour progression as well as tumour angiogenesis at protein and gene level. All VEGF signaling receptor markers expressions were significantly suppressed which were associated to significant tumour regression. Treatment with PF4 alone is not effective to inhibit the tumour angiogenesis. This was reflected in the insignificant inhibition of Flt-1, Flk-1 and Flt- 4 expression. The drug combination had obtained a significant down-regulation of Flt-1, Flk-1 and Flt-4 at protein and gene level but no synergistic effects were seen. Microvessel density counting had revealed that there is correlation (p<0.01) between the existing of capillary and the expression of VEGF signaling molecule receptors. Less capillary formation was observed in less aggressive tumours while the converse was seen in aggressive tumours. Thus, the present findings had suggested that rapamycin was not synergistic or additive to PF4. In fact, PF4 might be antagonist towards the action of rapamycin as anti-tumour and anti-angiogenesis. Present findings had concluded that rapamycin is a potent anti-angiogenic agent for the invasive NMU-induced mammary carcinoma in the rat model and has the potential to be applied clinically as an anti-angiogenic therapy for the treatment of advanced stages of breast cancer.
format	Thesis
qualification_level	Master's degree
author	Muhammad Sakri, Muhammad Shahidan
author_facet	Muhammad Sakri, Muhammad Shahidan
author_sort	Muhammad Sakri, Muhammad Shahidan
title	Analysis of VEGF receptors and microvessel density in NMU-induced breast cancer under the influence of platelet factor 4 and rapamycin
title_short	Analysis of VEGF receptors and microvessel density in NMU-induced breast cancer under the influence of platelet factor 4 and rapamycin
title_full	Analysis of VEGF receptors and microvessel density in NMU-induced breast cancer under the influence of platelet factor 4 and rapamycin
title_fullStr	Analysis of VEGF receptors and microvessel density in NMU-induced breast cancer under the influence of platelet factor 4 and rapamycin
title_full_unstemmed	Analysis of VEGF receptors and microvessel density in NMU-induced breast cancer under the influence of platelet factor 4 and rapamycin
title_sort	analysis of vegf receptors and microvessel density in nmu-induced breast cancer under the influence of platelet factor 4 and rapamycin
granting_institution	Universiti Sains Malaysia
granting_department	Pusat Pengajian Sains Perubatan
publishDate	2015
url	http://eprints.usm.my/40538/1/Dr._Muhammad_Shahidan_Muhammad_Sakri_%29-24_pages.pdf
_version_	1747820795658240000

Analysis of VEGF receptors and microvessel density in NMU-induced breast cancer under the influence of platelet factor 4 and rapamycin

Similar Items